Quadriplegia Treatment Market Size & Share, by Treatment Type (Corticosteroids, Non-Steroidal Anti-inflammatory Drugs, Antidepressants, Anticonvulsants, Narcotic Analgesics, Antispasmodics & Muscle Relaxants); Route of Administration (Oral, Intravenous); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Stores) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 3951
  • Published Date: Jan 12, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Quadriplegia Treatment Market size is poised to reach USD 4 Billion by the end of 2036, growing at a CAGR of 5% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of quadriplegia treatment was USD 2 Billion. The reason behind the growth is impelled by an increasing incidence of spinal cord injuries across the world. A spinal cord injury can result in loss of function or mobility, which can lead to quadriplegia or tetraplegia, as well as loss of muscle strength. For instance, more than 55% of severe spinal cord injury instances result in quadriplegia, making it the most prevalent symptom overall.

According to the World Health Organization (WHO), between 250,000 to 500,000 persons worldwide are affected by spinal cord injuries (SCI) each year.

The growing advancement in the field of quadriplegia treatment is believed to fuel the quadriplegia treatment market growth. For instance, researchers from Northwestern University researchers have devised a new injectable therapy that uses "dancing molecules" to mend spinal cord lesions, which gives hope to thousands of people affected annually who suffer serious spinal cord injuries and become paralyzed.


Quadriplegia Treatment Market
Get more information on this report: Request Free Sample PDF


Quadriplegia Treatment Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

~5%

Base Year Market Size (2023)

~ USD 2 Billion

Forecast Year Market Size (2036)

~ USD 4 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Quadriplegia Treatment Market: Growth Drivers and Challenges

Market-Growth-Drivers

Growth Drivers

  • Rising Geriatric Population - It is expected that elderly people are more prone to bone density-related problems such as osteoporosis, and other health problems that can become more common with age. In addition, there is a growing incidence of traumatic spinal cord injuries in the aged population, with falls appearing to be the primary source of these injuries resulting from weakened immune systems. According to recent research conducted around the world, the rate of falls among elderly persons ranges from over 3% to more than 30% and rises progressively with age. Furthermore, the number of individuals in the world who are 60 or older will rise to over 2 billion by 2050.
  • Increasing Sports-related Injuries - As a result, the chances of sports-related injuries including spinal cord injuries are also expected to rise leading to more cases of quadriplegia requiring treatment. For instance, the most dangerous sports for catastrophic spinal injuries are football, ice hockey, wrestling, and others. Amongst them, injuries to the cervical spine are thought to affect over 10% of football players. Besides this, spearing is also known as a significant contributor to quadriplegia and damage to the cervical spine.
  • Rising Prevalence of Spine Tumors- It is anticipated that there may be a correlation between this and a higher likelihood of quadriplegia in those who have the tumor. The spinal cord tumor spreads to the spinal cord leading to acute cervical spinal cord damage, tumor compression, and other conditions, which can cause quadriplegia since tumors have the potential to grow larger and squeeze nearby tissues. For instance, in 2020, there were projected to be more than 308,100 cases of primary brain or spinal cord tumors diagnosed globally, and in 2023, there will likely be around 5,220 new cases of CNS tumor diagnosis particularly, in the US among children under the age of 20.

Challenges

  • Exorbitant Cost of Quadriplegia Treatment - The cost of quadriplegia treatment depends on the severity of the damage, and the procedure also needs pricey equipment which requires frequent maintenance. Moreover, those who suffer total quadriplegia will incur significantly greater expenditures, as compared to those who suffer incomplete paraplegia. For instance, acute care costs in Australia ranged from around USD 42,500 for paraplegic patients to over USD 63,133 for quadriplegic patients.
  • Stringent Rules and Regulations May Create Barriers to Innovation and Delay in Bringing New Treatments to the Quadriplegia Treatment Market
  • Lack of Skilled Professionals in Lower Economic Regions Can Impact the Effectiveness of the Treatment


Quadriplegia Treatment Segmentation

Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Stores)

The hospital pharmacies segment in the quadriplegia treatment market is estimated to gain a robust revenue share of 60% in the coming years. Spinal cord injuries often require immediate medical attention, and hospitals provide 24*7 necessary facilities to provide quality care to the patient. The rising count of hospital admissions can also lead to higher demand for rehabilitation services for the treatment of quadriplegia. Lately, therapeutic and rehabilitation therapy services for those with spine injuries are provided acute rehabilitation in hospitals to recover and improve their mobility.

Route of Administration (Oral, Intravenous)

Quadriplegia treatment market from the oral segment is set to garner a notable share shortly. owing to the benefits offered by oral administration such as convenience, and cost-effectiveness. Patients with quadriplegia have limited mobility therefore oral route is considered as most convenient method. Physical therapy, occupational therapy, speech/language therapy, muscle relaxants, and the use of medical equipment are non-surgical treatments for quadriplegia, which may be used in combination with oral drugs or other treatments, this as a result also reduces the overall healthcare expenses. The treatment doesn’t require any surgical procedures or need for injections which are beneficial for patients who need long-term medical care and have weak immune systems.

Our in-depth analysis of the global quadriplegia treatment market includes the following segments:

        Treatment Type

  • Corticosteroids
  • Non- Steroidal Anti-inflammatory Drugs
  • Antidepressants
  • Anticonvulsants
  • Narcotic Analgesics
  • Antispasmodics & Muscle Relaxants

        Route of Administration

  • Oral
  • Intravenous

        Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Stores

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Quadriplegia Treatment Industry - Regional Synopsis

North American Market Forecast

Quadriplegia treatment market in North America is predicted to account for the largest share of 35% by 2036 impelled by the growing consumption of alcohol. Over the past few decades, there has been a rise in alcohol consumption per capita in the United States, which has increased the risk of health issues like cancer, and liver disorders, and is a component that regularly affects the likelihood of accidents and injuries. For instance, more than 35 individuals every day, or one every 39 minutes, lose their lives in drunk driving accidents in the United States.

According to estimates, more than 10 million adult Americans suffer from an alcohol consumption disorder. Particularly, in 2021 over 55% of American adults drank alcohol.

European Market Statistics

The Europe quadriplegia treatment market is estimated to be the second largest, during the forecast timeframe led by the increasing investment in the medical sector. As a result, there is an increase in the development of clinics, a rehabilitation hospital, and centers in the region that provide quality treatment services to patients with quadriplegia. Besides this, owing to increased spending healthcare professionals are also able to develop specialized skills for the treatment of quadriplegia leading to rising demand for the treatment.

Research Nester
Quadriplegia Treatment Market size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Quadriplegia Treatment Market

top-features-companies
    • Sanofi SA
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • AstraZeneca plc
    • GlaxoSmithKline plc
    • Johnson & Johnson Services, Inc.
    • Bristol Myers Squibb Company
    • Eli Lily & Company
    • Teva Pharmaceuticals, Inc.

In-the-news

In The News

  • A group of scientists, medical professionals, and researchers led by Battelle and The Ohio State University Wexner Medical Centre have shown for the first time that a person with a clinically complete spinal cord injury (SCI) can use a brain-computer interface (BCI) to simultaneously reanimate both motor function and sense of touch to improve quality of life and assist individuals in being more entire once again and less reliant on caregivers.
  • A team of Johns Hopkins neurosurgeons and biomedical engineers developed implantable ultrasound technology and other devices to completely change the way spinal cord injury patients are treated and to assist medical professionals in observing and managing the changes in blood flow and avoiding tissue death that happens right away after a spinal cord accident.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3951
  • Published Date: Jan 12, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The increasing incidence of spinal cord injuries across the world and the growing advancement in the field of quadriplegia treatment are the major factors driving the growth of the market.

The market size of quadriplegia treatment is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2024-2036.

The major players in the market are Sanofi SA, AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Bristol Myers Squibb Company, and others.

The hospital pharmacies segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Quadriplegia Treatment Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying